In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Crescent Capital BDC Inc (NASDAQ: CCAP) closed the day trading at $14.45 up 0.77% from the previous closing price of $14.34. In other words, the price has increased by $0.77 from its previous closing price. On the day, 0.16 million shares were traded. CCAP stock price reached its highest trading level at $14.57 during the session, while it also had its lowest trading level at $14.3322.
Ratios:
For a better understanding of CCAP, let’s look at its different ratios.
On September 30, 2024, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $20.
Wells Fargo Downgraded its Overweight to Equal Weight on November 13, 2023, whereas the target price for the stock was revised from $16.50 to $16.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CCAP now has a Market Capitalization of 535538656 and an Enterprise Value of 1426458368. As of this moment, Crescent’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.78, and their Forward P/E ratio for the next fiscal year is 8.59. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.83 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 7.542.
Stock Price History:
The Beta on a monthly basis for CCAP is 0.60, which has changed by -0.23056442 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, CCAP has reached a high of $20.07, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -5.89%, while the 200-Day Moving Average is calculated to be -18.45%.
Shares Statistics:
Over the past 3-months, CCAP traded about 195.42K shares per day on average, while over the past 10 days, CCAP traded about 338800 shares per day. A total of 37.06M shares are outstanding, with a floating share count of 28.14M. Insiders hold about 12.55% of the company’s shares, while institutions hold 61.07% stake in the company. Shares short for CCAP as of 1748563200 were 210584 with a Short Ratio of 1.08, compared to 1745971200 on 236800. Therefore, it implies a Short% of Shares Outstanding of 210584 and a Short% of Float of 0.91.
Dividends & Splits
CCAP’s forward annual dividend rate is 1.67, up from 1.68 a year ago. Against a Trailing Annual Dividend Yield of 0.11715481The stock’s 5-year Average Dividend Yield is 9.4.
Earnings Estimates
The firm’s stock currently is rated by 6.0 analysts. The consensus estimate for the next quarter is $0.46, with high estimates of $0.5 and low estimates of $0.44.
Analysts are recommending an EPS of between $1.93 and $1.79 for the fiscal current year, implying an average EPS of $1.83. EPS for the following year is $1.68, with 6.0 analysts recommending between $1.74 and $1.56.
Revenue Estimates
5 analysts predict $42.52M in revenue for the current quarter. It ranges from a high estimate of $44.1M to a low estimate of $41.92M. As of the current estimate, Crescent Capital BDC Inc’s year-ago sales were $48.95MFor the next quarter, 5 analysts are estimating revenue of $42.03M. There is a high estimate of $43.5M for the next quarter, whereas the lowest estimate is $41.25M.
A total of 5 analysts have provided revenue estimates for CCAP’s current fiscal year. The highest revenue estimate was $171.9M, while the lowest revenue estimate was $165.82M, resulting in an average revenue estimate of $167.72M. In the same quarter a year ago, actual revenue was $197.36MBased on 5 analysts’ estimates, the company’s revenue will be $158.4M in the next fiscal year. The high estimate is $163.47M and the low estimate is $152.27M.
